Medindia

X

Sanofiís Dengue Vaccine Meets Goal in Clinical Trial

by Kathy Jones on  November 4, 2014 at 8:49 PM Corporate News   - G J E 4
French pharmaceutical giant Sanofi revealed that its experimental dengue vaccine has managed to meet its primary goal during a late stage clinical trial and was found to be highly effective even against the most severe type of the disease.
 Sanofiís Dengue Vaccine Meets Goal in Clinical Trial
Sanofiís Dengue Vaccine Meets Goal in Clinical Trial
Advertisement

The trial was conducted in Brazil and Latin America and the researchers revealed that it was 95.5 percent effective in treating severe cases of dengue, including the hemorrhagic type.

Advertisement
More than 31,000 people from 10 endemic countries from Asia and Latin America took part in the study and the company revealed that the vaccine, claimed to be the world's first against dengue fever, will be made available by the second half of 2015 subject to regulatory approval.


Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All